Törnblom M - Search Results

1

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O. Törnblom M, et al. Urology. 1999 May;53(5):945-50. doi: 10.1016/s0090-4295(98)00640-2. Urology. 1999. PMID: 10223488

2

Seminal vesicle metastasis--an overlooked occurrence of testicular tumours?

Törnblom M, Fredriksson A, Larsson P, Zimmermann R, Hedenborg L. Törnblom M, et al. Br J Urol. 1996 Jan;77(1):160-2. doi: 10.1046/j.1464-410x.1996.87035.x. Br J Urol. 1996. PMID: 8653297 No abstract available.

3

MRI, CT, and TRUS imaging of seminal vesicle metastasis.

Larsson P, Biomqvist L, Törnblom M, Norming U. Larsson P, et al. Among authors: tornblom m. Eur Radiol. 1997;7(4):555-6. doi: 10.1007/s003300050203. Eur Radiol. 1997. PMID: 9204339 No abstract available.

4

Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer--a study of a randomly selected population of 2,400 men.

Gustafsson O, Mansour E, Norming U, Carlsson A, Törnblom M, Nyman CR. Gustafsson O, et al. Among authors: tornblom m. Scand J Urol Nephrol. 1998 Dec;32(6):373-7. doi: 10.1080/003655998750015124. Scand J Urol Nephrol. 1998. PMID: 9924998

5

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.

Törnblom M, Norming U, Becker C, Lilja H, Gustafsson O. Törnblom M, et al. BJU Int. 2001 May;87(7):638-42. doi: 10.1046/j.1464-410x.2001.02143.x. BJU Int. 2001. PMID: 11350403

6

Antibiotic prophylaxis for prostate biopsy: benefits and costs.

Larsson P, Norming U, Törnblom M, Gustafsson O. Larsson P, et al. Among authors: tornblom m. Prostate Cancer Prostatic Dis. 1999 Mar;2(2):88-90. doi: 10.1038/sj.pcan.4500294. Prostate Cancer Prostatic Dis. 1999. PMID: 12496844

7

Lead time associated with screening for prostate cancer.

Törnblom M, Eriksson H, Franzén S, Gustafsson O, Lilja H, Norming U, Hugosson J. Törnblom M, et al. Int J Cancer. 2004 Jan 1;108(1):122-9. doi: 10.1002/ijc.11554. Int J Cancer. 2004. PMID: 14618626 Free article.

8

The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.

Varenhorst E, Garmo H, Holmberg L, Adolfsson J, Damber JE, Hellström M, Hugosson J, Lundgren R, Stattin P, Törnblom M, Johansson JE. Varenhorst E, et al. Among authors: tornblom m. Scand J Urol Nephrol. 2005;39(2):117-23. doi: 10.1080/00365590510007793. Scand J Urol Nephrol. 2005. PMID: 16019764

9

Geographical variation in incidence of prostate cancer in Sweden.

Stattin P, Johansson R, Lodnert R, Andrén O, Bill-Axelsson A, Bratt O, Damber JE, Hellström M, Hugosson J, Lundgren R, Törnblom M, Varenhorst E, Johansson JE. Stattin P, et al. Among authors: tornblom m. Scand J Urol Nephrol. 2005;39(5):372-9. doi: 10.1080/00365590500375463. Scand J Urol Nephrol. 2005. PMID: 16257838

10

Oral oxycodone hydrochloride versus epidural anaesthesia for pain control after radical retropubic prostatectomy.

Hohwü L, Akre O, Bergenwald L, Törnblom M, Gustafsson O. Hohwü L, et al. Among authors: tornblom m. Scand J Urol Nephrol. 2006;40(3):192-7. doi: 10.1080/00365590600589583. Scand J Urol Nephrol. 2006. PMID: 16809258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page